vs
Side-by-side financial comparison of VIEMED HEALTHCARE, INC. (VMD) and Voyager Technologies, Inc. (VOYG). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $35.2M, roughly 2.2× Voyager Technologies, Inc.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -130.4%, a 137.8% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 2.1%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-66.8M).
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
VMD vs VOYG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $76.2M | $35.2M |
| Net Profit | $5.6M | $-45.9M |
| Gross Margin | 57.9% | -4.4% |
| Operating Margin | 11.0% | — |
| Net Margin | 7.4% | -130.4% |
| Revenue YoY | 25.5% | 2.1% |
| Net Profit YoY | 30.7% | -64.5% |
| EPS (diluted) | $0.14 | $-0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $35.2M | ||
| Q4 25 | $76.2M | $46.7M | ||
| Q3 25 | $71.9M | $39.6M | ||
| Q2 25 | $63.1M | $45.7M | ||
| Q1 25 | $59.1M | — | ||
| Q4 24 | $60.7M | — | ||
| Q3 24 | $58.0M | — | ||
| Q2 24 | $55.0M | — |
| Q1 26 | — | $-45.9M | ||
| Q4 25 | $5.6M | $-33.0M | ||
| Q3 25 | $3.5M | $-16.3M | ||
| Q2 25 | $3.2M | $-31.4M | ||
| Q1 25 | $2.6M | — | ||
| Q4 24 | $4.3M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $1.5M | — |
| Q1 26 | — | -4.4% | ||
| Q4 25 | 57.9% | 21.4% | ||
| Q3 25 | 57.5% | 15.4% | ||
| Q2 25 | 58.3% | 18.0% | ||
| Q1 25 | 56.3% | — | ||
| Q4 24 | 59.5% | — | ||
| Q3 24 | 59.3% | — | ||
| Q2 24 | 59.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.0% | — | ||
| Q3 25 | 7.8% | -60.7% | ||
| Q2 25 | 8.1% | -52.8% | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 10.6% | — | ||
| Q3 24 | 9.7% | — | ||
| Q2 24 | 6.6% | — |
| Q1 26 | — | -130.4% | ||
| Q4 25 | 7.4% | -70.7% | ||
| Q3 25 | 4.9% | -41.1% | ||
| Q2 25 | 5.0% | -68.7% | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 7.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 2.7% | — |
| Q1 26 | — | $-0.75 | ||
| Q4 25 | $0.14 | $-0.52 | ||
| Q3 25 | $0.09 | $-0.28 | ||
| Q2 25 | $0.08 | $-1.23 | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.10 | — | ||
| Q2 24 | $0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.5M | $429.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $141.5M | $404.5M |
| Total Assets | $199.2M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $429.4M | ||
| Q4 25 | $13.5M | $491.3M | ||
| Q3 25 | $11.1M | $413.3M | ||
| Q2 25 | $20.0M | $468.9M | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | $17.5M | — | ||
| Q3 24 | $11.3M | — | ||
| Q2 24 | $8.8M | — |
| Q1 26 | — | $404.5M | ||
| Q4 25 | $141.5M | — | ||
| Q3 25 | $133.6M | $590.9M | ||
| Q2 25 | $139.7M | $554.7M | ||
| Q1 25 | $134.8M | — | ||
| Q4 24 | $131.4M | — | ||
| Q3 24 | $125.0M | — | ||
| Q2 24 | $119.4M | — |
| Q1 26 | — | $1.0B | ||
| Q4 25 | $199.2M | — | ||
| Q3 25 | $202.4M | $727.8M | ||
| Q2 25 | $184.6M | $685.3M | ||
| Q1 25 | $178.1M | — | ||
| Q4 24 | $177.1M | — | ||
| Q3 24 | $169.5M | — | ||
| Q2 24 | $163.9M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.4M | $-39.7M |
| Free Cash FlowOCF − Capex | $9.7M | $-66.8M |
| FCF MarginFCF / Revenue | 12.7% | -189.5% |
| Capex IntensityCapex / Revenue | 11.5% | — |
| Cash ConversionOCF / Net Profit | 3.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $11.9M | $-263.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-39.7M | ||
| Q4 25 | $18.4M | $-60.9M | ||
| Q3 25 | $18.4M | $-15.1M | ||
| Q2 25 | $12.3M | $-30.9M | ||
| Q1 25 | $2.9M | — | ||
| Q4 24 | $15.0M | — | ||
| Q3 24 | $12.7M | — | ||
| Q2 24 | $10.2M | — |
| Q1 26 | — | $-66.8M | ||
| Q4 25 | $9.7M | $-54.5M | ||
| Q3 25 | $10.7M | $-53.8M | ||
| Q2 25 | $4.1M | $-88.8M | ||
| Q1 25 | $-12.6M | — | ||
| Q4 24 | $3.2M | — | ||
| Q3 24 | $1.7M | — | ||
| Q2 24 | $1.2M | — |
| Q1 26 | — | -189.5% | ||
| Q4 25 | 12.7% | -116.9% | ||
| Q3 25 | 14.9% | -135.8% | ||
| Q2 25 | 6.5% | -194.4% | ||
| Q1 25 | -21.4% | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 2.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.5% | — | ||
| Q3 25 | 10.6% | 97.8% | ||
| Q2 25 | 12.9% | 126.7% | ||
| Q1 25 | 26.2% | — | ||
| Q4 24 | 19.5% | — | ||
| Q3 24 | 19.0% | — | ||
| Q2 24 | 16.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.27× | — | ||
| Q3 25 | 5.23× | — | ||
| Q2 25 | 3.88× | — | ||
| Q1 25 | 1.09× | — | ||
| Q4 24 | 3.47× | — | ||
| Q3 24 | 3.29× | — | ||
| Q2 24 | 6.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
